GANX Gain Therapeutics, Inc.
Healthcare$1.78+1.71%ClosedMarket Cap: $75.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$9.00
Target (Median)
$9.00
Target Range
$8.00 - $10.00
Upside from current price: 405.6%
Rating Distribution
1 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2025-12-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-15 | BTIG | maintain | Buy | Buy |
| 2025-10-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-07 | Maxim Group | maintain | Buy | Buy |
| 2025-09-08 | BTIG | maintain | Buy | Buy |
| 2025-08-13 | Roth Capital | maintain | Buy | Buy |
| 2025-07-03 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-0.71 | $50.0K | 4 |
| Fri Dec 31 | $-0.74 | $225.0K | 3 |
| Sun Dec 31 | $-0.76 | $100.3M | 2 |
| Mon Dec 31 | $-0.02 | $48.1M | 1 |